|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/22/21 Sigma Labs, Inc. 10-Q 3/31/21 44:2.7M M2 Compliance LLC/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 199K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 18K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 18K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 15K
11: R1 Document and Entity Information HTML 43K
12: R2 Condensed Balance Sheets (Unaudited) HTML 124K
13: R3 Condensed Balance Sheets (Unaudited) HTML 32K
(Parenthetical)
14: R4 Condensed Statements of Operations (Unaudited) HTML 105K
15: R5 Statement of Stockholders' Equity (Unaudited) HTML 90K
16: R6 Condensed Statements of Cash Flows (Unaudited) HTML 100K
17: R7 Summary of Significant Accounting Policies HTML 38K
18: R8 Inventory HTML 20K
19: R9 Deferral of Social Security Tax Payments HTML 17K
20: R10 Derivative Liability HTML 27K
21: R11 Stockholders' Equity HTML 76K
22: R12 Subsequent Events HTML 17K
23: R13 Summary of Significant Accounting Policies HTML 49K
(Policies)
24: R14 Summary of Significant Accounting Policies HTML 38K
(Tables)
25: R15 Inventory (Tables) HTML 20K
26: R16 Derivative Liability (Tables) HTML 25K
27: R17 Stockholders' Equity (Tables) HTML 59K
28: R18 Summary of Significant Accounting Policies HTML 21K
(Details Narrative)
29: R19 Summary of Significant Accounting Policies - HTML 17K
Schedule of Warrant Liability Measured on
Recurring Basis (Details)
30: R20 Summary of Significant Accounting Policies - HTML 20K
Schedule of Derivative Liability Measured on a
Recurring Basis Using Significant Unobservable
Input (Level 3) (Details)
31: R21 Summary of Significant Accounting Policies - HTML 24K
Schedule of Antidilutive Securities Excluded from
Computation of Earnings Per Share (Details)
32: R22 Summary of Significant Accounting Policies - HTML 22K
Schedule of Earnings Per Share, Basic and Diluted
(Details)
33: R23 Inventory - Schedule of Inventory (Details) HTML 23K
34: R24 Deferral of Social Security Tax Payments (Details HTML 21K
Narrative)
35: R25 Derivative Liability (Details Narrative) HTML 27K
36: R26 Derivative Liability - Schedule of Fair Value of HTML 26K
Derivative Liability Using Black Scholes Valuation
Model (Details)
37: R27 Derivative Liability - Schedule of Fair Value of HTML 23K
Warrant Liability (Details)
38: R28 Stockholders' Equity (Details Narrative) HTML 167K
39: R29 Stockholders' Equity - Schedule of Share-based HTML 31K
Payment Award, Stock Options, Valuation
Assumptions (Details)
40: R30 Stockholders' Equity - Schedule of Stock Option HTML 101K
Activity (Details)
41: R31 Stockholders' Equity - Summary of Warrant Activity HTML 40K
(Details)
43: XML IDEA XML File -- Filing Summary XML 74K
42: EXCEL IDEA Workbook of Financial Reports XLSX 50K
5: EX-101.INS XBRL Instance -- sglb-20210331 XML 722K
7: EX-101.CAL XBRL Calculations -- sglb-20210331_cal XML 122K
8: EX-101.DEF XBRL Definitions -- sglb-20210331_def XML 314K
9: EX-101.LAB XBRL Labels -- sglb-20210331_lab XML 741K
10: EX-101.PRE XBRL Presentations -- sglb-20210331_pre XML 495K
6: EX-101.SCH XBRL Schema -- sglb-20210331 XSD 116K
44: ZIP XBRL Zipped Folder -- 0001493152-21-009466-xbrl Zip 80K
Exhibit 31.1
Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, Mark K Ruport, certify that:
1. I have reviewed this Quarterly Report on Form 10-Q of Sigma Labs, Inc.;
2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;
3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: April 22, 2021
| By: | /s/ Mark K. Ruport | |
| Name: | Mark K. Ruport | |
| Title: | President and Chief Executive Officer | |
| (Principal Executive Officer) |
C:
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 4/22/21 | 8-K | ||
| For Period end: | 3/31/21 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/14/23 Sigma Additive Solutions, Inc. 424B5 1:457K M2 Compliance LLC/FA 9/14/21 Sigma Additive Solutions, Inc. S-8 9/14/21 3:198K M2 Compliance LLC/FA 8/10/21 Sigma Additive Solutions, Inc. S-8 8/10/21 3:127K M2 Compliance LLC/FA 7/02/21 Sigma Additive Solutions, Inc. 424B5 1:524K M2 Compliance LLC/FA 6/21/21 Sigma Additive Solutions, Inc. 424B3 1:227K M2 Compliance LLC/FA 6/11/21 Sigma Additive Solutions, Inc. S-3 4:1.1M M2 Compliance LLC/FA 6/09/21 Sigma Additive Solutions, Inc. S-3 3:337K M2 Compliance LLC/FA |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/30/21 Sigma Additive Solutions, Inc. 8-K:1,3,8,9 3/25/21 7:589K M2 Compliance LLC/FA 1/12/21 Sigma Additive Solutions, Inc. 8-K:1,3,8,9 1/08/21 9:676K M2 Compliance LLC/FA |